Navigation Links
novo in Medical News

Diabetes Experts Partner With Novo Nordisk to Provide New Patient Materials

HOUSTON, May 14 /PRNewswire-USNewswire/ -- A free resource designed to educate patients about ways to successfully manage their diabetes was revealed today at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress. (Logo: http://www.new...

Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S.

No. 1 Selling Prefilled Insulin Pen in the World Available with Levemir(R), NovoLog(R) and NovoLog(R) Mix 70/30 PRINCETON, N.J., March 2 /PRNewswire-FirstCall/ -- Novo Nordisk has redesigned FlexPen(R), the number one selling pre-filled insulin pen in the world(1), to allow diabetes patie...

Shared Health(R) and Novo Innovations Partner for Improved Information-Sharing of Clinical Health Records

CHATTANOOGA, Tenn., May 19 /PRNewswire/ -- Shared Health, Inc., one of the nation's largest public/private health information exchanges (HIE), and Novo Innovations, the leading healthcare provider of software agent technologies for health information exchange, are partnering to provide improve...

FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors

First Recombinant Room Temperature Stable Treatment for Hemophilia With Inhibitors Offers More Flexibility and Convenience to Patients PRINCETON, N.J., May 13 /PRNewswire-FirstCall/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved NovoSeven(R) RT ...

Astute Medical Raises $6.2 Million in Series A Financing Round Led by De Novo Ventures

SAN DIEGO, May 1 /PRNewswire/ -- Astute Medical, Inc. today announced it has raised $6.25 million in an initial financing round led by De Novo Ventures. The proceeds will primarily be used to fund research and development aimed at the identification and validation of protein biomarkers with th...

Novo Nordisk Appoints Per Falk, M.D., Ph.D., as Vice President for Clinical, Medical and Regulatory Affairs for North America

... PRINCETON, N.J., Aug. 5 /PRNewswire-FirstCall/ -- novo Nordisk, a global healthcare company focusing on d... will report directly to Jerzy Gruhn, president of novo Nordisk Inc., the novo Nordisk U.S. affiliate, and senior vice president ...

LCA-Vision Reports Second Quarter Financial Results

...d investments conservatively in 2009. The company does not plan to open any new vision centers in 2009. LCA-Vision plans to restart its de novo new center opening program following improvements in the economy. The company will continue to manage general and administrative expenses aggre...

Lutonix, Inc. Announces First Patient Enrollments in Three Separate Clinical Trials

...an Duda of the Jewish Hospital in Berlin, Germany. The Lutonix De novo Pilot Study The Lutonix De novo study will assess the interaction between bare metal stents and the Lutonix...

Prescient Medical Receives Frost & Sullivan Product Innovation of the Year Award

...earch Analyst, Frost & Sullivan. The vProtect(TM) Luminal Shield recently completed phase 1 first-in-human trials for the treatment of de novo obstructive coronary lesions. The Shield is also being evaluated in an investigator-sponsored study known as the SECRITT I (Santorini Criteria for Inv...

Is RTA a new potential option for the treatment of hydatid cysts?

...liver, and 1.57 cm for lung, was also seen. The endocyst remained attached to the pericystium both in hepatic and lung cysts, with small and focal de novo detachment in just 3/9 hepatic cysts. Finally, after treatment, the authors found immediate volume reduction of the cysts of at least 65%. The rese...
novo in Medical Technology

12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions

'New Class' of Stent with Polyzene(R)-F Surface Treatment Maximizes Endothelialization; Reduces Restenosis, Thrombogenicity, Need for Long-Term Dual Antiplatelet Therapy WASHINGTON, Oct. 13 /PRNewswire/ -- Clinical investigators at today's "Innovative Devices and Futuristic Therapies" sessio...

Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market

Owing to Well-Established and Effective Insulin-Based Therapies, Market Growth Will be Modest Through 2017, According to a New Report from Decision Resources WALTHAM, Mass., Aug. 12 /PRNewswire/ -- Decision Resources, one of the world's leading research and adviso...

FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)

...he FDA on May 2, 2006, and is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British (FAB) subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia wit...

Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia

...e inhibition with potential in the areas of oncology and inflammation. The company's investors include MVM Life Science Partners, SV Life Sciences and novo A/S. Vantia Therapeutics is situated on Southampton Science Park, UK, where it occupies 10,000 sq ft of chemistry and biology facilities. For further ...

More Gene Mutations Linked to Autism Risk

...plexity, in which many different gene changes may contribute to an autism spectrum disorder. "We are finding that both inherited and new, or de novo , genetic mutations are scattered throughout the genome and we suspect that different combinations of these variations contribute to autism susceptibi...

The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide

... The Lancet published online the results of the novo Nordisk (NVO) LEAD(TM) 6 study, a direct compariso...ndigestion, nausea, common cold and headache. novo Nordisk announced results from the LEAD(TM) 6 stud...ot require renal excretion. On May 23, 2008, novo Nordisk submitted a New Drug Application to the Fo...

Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162

... NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- novo Nordisk (NVO) data presented today at the 69th Ann...ot require renal excretion. On May 23, 2008, novo Nordisk submitted a New Drug Application to the Fo...in Japan on July 14, 2008. On April 23, 2009, novo Nordisk announced that the Committee for Medicinal...

Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting

... 12 months. This study indicated that cartilage defects treated with the CRD repaired more rapidly than controls. The data also suggested that the de novo tissue formed in the CRD at 12 months is mechanically sound and durable, and resembles natural articular cartilage. Both studies showed that the CR...

TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry

...tions rate implants infections rate De novo 15 0 0.0% 51 ...tions rate implants infections rate De novo 1 0 0.0% 67 ...ctions rate implants infections rate De novo 15 0 0.0% 51 ...

Logical Therapeutics Appoints Peter A. Lankau as CEO and Director

... on the development of products that treat diseases associated with inflammation. Logical's investors include S V Life Sciences, Burrill and Company, novo Ventures A/S, and Novitas Capital. For more information on Logical Therapeutics, visit the company's website at www.logicaltherapeutics.com . ...
novo in Medical Products

ABI PRISM 310 Genetic Analyzer

Description:...nalyzer -- the ideal alternative to gel-based DNA analysis for any research, clinical, or forensic lab -- enables you to automate applications from de novo sequencing to SNP validation and linkage mapping. This versatile analyzer is so easy to use, that once it is installed and you have completed our shor...
Company:Applied Biosystems

TAXUS Express2 Monorail Paclitaxel-Eluting Coronary Stent System

Description:... The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3.75 mm in diameter....
Company:Boston Scientific Corporation

TAXUS Express2 Over-the-wire Paclitaxel-Eluting Coronary Stent System

Description:... The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3.75 mm in diameter....
Company:Boston Scientific Corporation

CEQ 8000 Genetic Analysis System

Features:... De novo DNA Sequencing. Heterozygote detection. Confirmatory sequencing. Mutation analysis. Allele identification. SNP scoring. Microsatellite instability. AF...
Company:Beckman Coulter, Inc.

CEQ™ 8000 Genetic Analysis System

Features:... De novo DNA Sequencing. Heterozygote detection. Confirmatory sequencing. Mutation analysis. Allele identification. SNP scoring. Microsatellite instability. AF...
Company:Beckman Coulter, Inc.
novo in Biological News

Genomatix technology facilitates de novo identification of new renal disease associated genes

Previously unknown molecules and regulatory pathways in human glomerular diseases have been identified by a joint effort of the Medizinische Poliklinik, Munich, the University of Bristol´s Children´s Renal Unit, the German Cancer Research Center, sanofi-aventis, and Genomatix Software GmbH. In a ...

Funxional successfully completes initial clinical trial of FX125L, an anti-inflammatory drug with a novel mechanism of action

... in Cambridge (UK) which focuses on novel anti-inflammatory therapies. FXT is managed by a very experienced team and is financed by Index Ventures and novo A/S, while its shareholders also include Ipsen and Cambridge University. FXT has research and office facilities in Cambridge. For more information ab...

The evolutionary foundation of genomic imprinting in lower vertebrates

...d that, unlike mammalian imprinting gene DMR, the unmethylated DMR of maternal allele could not resist methylation reprogramming and started de novo methylation at the cleavage stage, while the paternal Igf2 allele appeared to maintain its paternal methylation imprints during embryogenesis. These r...

New genomic technique uncovers coral transcriptome

...sity, led by Mikhail Matz and John Colbourne, developed a new method for transcriptome analysis based on next-generation 454 sequencing technology. De novo transcriptome analysis is a cost-efficient alternative to genome sequencing when the goal is discovery of protein-coding genes and genetic markers. Ac...

Boehringer Ingelheim uses Genomatix' Next Generation Sequencing data analysis systems

...which allows for splice junction analysis and identification of new transcriptional units. For genomic re-sequencing and newly sequenced genomes, a de novo assembly will be provided. The Genomatix Genome Analyzer (GGA) delivers downstream software tools and databases for the deep biological analysis of...

Genomatix joins Illumina-Connect program

... which allows for splice junction analysis and identification of new transcriptional units.For genomic re-sequencing and newly sequenced genomes, a de novo assembly will be provided. The GGA delivers downstream software tools and databases for the deep biological analysis of genomic position data coming ...

UC San Diego and Genentech scientists develop potentially disruptive antibody sequencing technology

... industry researchers today. The breakthrough is detailed in the December 2008 issue of Nature Biotechnology , in an article titled, "Automated de novo protein sequencing of monoclonal antibodies." In it, the authors propose a new shotgun protein sequencing method, which reduces the time required to s...

Researchers solve piece of large-scale gene silencing mystery

...R-LIKE 3 (DCL3), an enzyme that chops up RNA transcripts into smaller segments. These smaller fragments of RNA become siRNAs, which then guide the de novo cytosine methyltransferase , DRM2, to the targeted genes. DRM2 is required to put a methyl group, a chemical flag that signals for silencing, on ribo...

Dictyostelium cells shown to lay 'breadcrumb trail' as first step in multicellular formation

...into intracellular vesicles that cluster at the rear of cells in a process that is dependent on actin and microtubule networks. They also show that de novo protein synthesis is required to maintain the asymmetrical distribution of the ACA vesicles. Interestingly, the ACA-containing vesicles themselves,...

New type of vaccines deliver stronger and faster immune response

...ng major outbreaks. The Scandinavian company novo A/S and the novo Nordisk Foundation have such faith in the new tech...e of the platform. "The grants awarded through our novo Seeds programme are only for very select projects ...
novo in Biological Technology

BioMed Realty Trust Announces 36,900 Square Foot Lease in Seattle With Novo Nordisk

SAN DIEGO, Oct. 22 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR ) today announced the signing of a new lease at its 530 Fairview Avenue property in Seattle, Washington. A wholly owned subsidiary of Novo Nordisk A/S, a healthcare company and world leader in diabetes care, has...

Dancing With the Stars' Drew Lachey and Novo Nordisk Launch Dancin' to Change Diabetes National Video Contest

PRINCETON, N.J., May 6 /PRNewswire/ -- WHAT: ABC's Dancing with the Stars champion Drew Lachey has teamed up with Novo Nordisk, a world leader in diabetes care, to launch the first national online video contest to increase diabetes awareness, Dan...

Medarex to Receive Milestone Payment from Novo Nordisk

PRINCETON, N.J., March 31 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) today announced that it will receive a milestone payment for an undisclosed amount from its licensing partner, Novo Nordisk A/S. This payment is a result of the submission of an Investigational New Drug applicat...

Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S

VIENNA, Austria, November 28 /PRNewswire/ -- f-star, an antibody engineering company developing novel antibodies and antibody fragments based on its unique Modular Antibody Technology, today announced that it has raised EUR 3.0 million from Novo A/S in a Second Closing of its Series A financin...

Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIG's Plenary Panel in Vegas

NEW YORK, Sept. 17 /PRNewswire/ -- iiBIG's New Directions for Drug Delivery: Emerging Modes, Novel Science and Profitable Deal Strategies conference is scheduled for October 29-30, 2007, at the Flamingo in Las Vegas, Nevada. The sessions will cover developments in controlled release technologi...

Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody

...include: Nomura Phase4 Ventures, US Venture Partners, Latterell Venture Partners, Morgenthaler Ventures, The Vertical Group, Adams Street Partners, De novo Ventures, Delphi Ventures, Bay Partners and GlaxoSmithKline. Additional information can be found at the company's website: www.oncomed.com . ...

Nuevolution Announces Worldwide Technology Cross-Licensing Agreement With GSK

...tely owned company and has raised EUR 37 million in financing from key Scandinavian investors, including SEB Venture, Sunstone Capital, SLS Invest and novo A/S. For more information about Nuevolution A/S, please visit the company's website http://www.nuevolution.com For further information pleas...

Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payer Access & Insights

... content collected from 11 participating companies including Abbott Labs, Alcon, Amgen, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, novo Nordisk, Sepracor, Solvay, Ther-Rx and Xanodyne Pharmaceuticals . A Report excerpt, " Understanding Managed Markets: Effective Market Res...

New drugs faster from natural compounds: A UC San Diego breakthrough

...der to determine the chemical structure of a cyclic NRP. This is called "De novo sequencing of NRPs." Second, the researchers created "dereplication" too...nd is a glimpse into the future of modern drug discovery." Performing de novo sequencing without knowing amino acid masses is completely novel, according...

Funxional Successfully Completes Initial Clinical Trial of FX125L, an Anti-Inflammatory Drug With a Novel Mechanism of Action

... in Cambridge (UK) which focuses on novel anti-inflammatory therapies. FXT is managed by a very experienced team and is financed by Index Ventures and novo A/S, while its shareholders also include Ipsen and Cambridge University . FXT has research and office facilities in Cambridge. For more inform...
novo in Biological Products

AXIMA-CFR MALDI TOF from Shimadzu Biotech

Description:...AUNCHPAD software features many unique functions for proteomics and enables access to protein databases for sequence searching without the need for de novo sequencing or creation of sequence tags....
Company:Shimadzu Biotech

DNA Polymerase I from Promega

Description:...o replace nucleotides in the growing strand of DNA by nick translation (1). The enzyme, purified from recombinant E. coli, is capable of catalyzing de novo synthesis of synthetic homopolymers and provides a convenient method for the preparation of a variety of defined DNA substrates (2)....
Company:Promega

Mass Spectrometry Service using MALDI-TOF/TOF from Applied Biomics, Inc.

Description:... by MALDI-TOF/TOF. The masses and sequences will be used to search in a protein database to precisely determine the protein identity. We also offer de novo protein sequencing....
Company:Applied Biomics, Inc.

Genome Sequencer 20 System from Roche Applied Science

Description:...: Instrument and accessories Reagents and consumables for library construction, amplification, and sequencing Analysis software for mapping and de novo assembly The instrument is the centerpiece of the Genome Sequencer 20 System. It contains both optics and fluidics subsystems, which are controlled...
Company:Roche Applied Science
novo in Biological Definition

Bioinformatics

...rtually identical, which reflects their near identical purposes. Other techniques for predicting protein structure include protein threading and de novo (from scratch) physics-based modeling. See also structural motif . Modeling biological systems Main article: Systems biology Systems ...

Bioinformatics

...rtually identical, which reflects their near identical purposes. Other techniques for predicting protein structure include protein threading and de novo (from scratch) physics-based modeling. See also structural motif . Modeling biological systems Main article: Systems biology Systems ...

Endosymbiotic theory

..., allowing cells to withstand growing amounts of free molecular oxygen in the Earth's atmosphere. However, it now appears that they may be formed de novo , contradicting the idea that they have a symbiotic origin. Evidence Evidence that mitochondria and chloroplasts arose via an ancient endosym...

Insulin

... preparations of insulin (from the major suppliers – Eli Lilly and novo Nordisk -- or from any other) are never just 'insulin in water'. Clinical ...sorbed rapidly enough to mimic real beta cell insulin (Lilly's is 'lispro', novo Nordisk's is 'aspart'), or steadily absorbed after injection instead of...

Proteomics

...adation. Higher-throughput proteomic techniques are based on mass spectrometry , commonly peptide mass fingerprinting on simpler instruments, or de novo sequencing on instruments capable of more than one round of mass spectrometry. Antibody-based assays can also be used, but are unique to one protein....
novo in Biological Dictionary

Transcriptome

...e tools to determine and ... Some papers, using our transcriptome data, have already been published: ... Genome & DNA Sequencing Services, De novo Assembly, Mapping of Genomic DNA, PCR, & MicroRNA. ... Maher et al. Transcriptome sequencing to detect gene fusions ... Fully Supported ...

Sequence homology

... and cohomology groups.... BSI provides superior bioninformaticssolutions software ... from the database that show significant homology to the de novo sequence . ... Sequence Tag Homology Page ... In most cases of homology modeling, we have the sequence of a protein for which ... Seque...

Pyrimidine

...thesis. v • d • e ... Nucleotide metabolism: Purine metabolism · Nucleotide salvage · Pyrimidine metabolism ... Pyrimidine Catabolism. De novo Synthesis of Purine Nucleotides ... The purine and pyrimidine bases released are either degraded or salvaged for ... Pyrimidine is a hetero...

Purine

...s ... does purine mean? Read answer... What are Purine foods? ... De novo Synthesis of Purine Nucleotides. De novo Synthesis of Pyrimidine Nucleotides ... The names of purine nucleosides e...

Prokaryote

...earch from Academic Journals, Newspapers, and magazines at HighBeam.com. Free Trial, Credit Card Required. Genome & DNA Sequencing Services, De novo Assembly, Mapping of Genomic DNA, PCR, & MicroRNA. ... 454 Home > Applications > Prokaryote Whole Genome. Overview ... Prokaryotes ar...
Other Tags
(Date:11/23/2014)... NY (PRWEB) November 23, 2014 ... allege heart attacks, strokes, deep vein thrombosis and ... in a federal multidistrict litigation (MDL) underway in ... reports. , Court documents updated on November ... Litigation (JPML) show the filing of 259 lawsuits ...
(Date:11/23/2014)... This evaluation provides a basic ... programs and manufacturing technological innovation. Then, the evaluation ... gamers in information. In this part, the evaluation ... value, and 2009-2014 market shares for each company. ... globally and Chinese suppliers finish market of Femoral ...
(Date:11/23/2014)... 2014 AngelWeddingDress.com has recently ... selection of beach wedding dresses. “If you are looking ... AngelWeddingDress.com as soon as possible. Here you can enjoy ... manager says. , Holding a big marriage ceremony is ... a beautiful beach wedding dress is uppermost priority. Ophelia, ...
(Date:11/23/2014)... Columbus, OH (PRWEB) November 23, 2014 ... Schulte LLC on behalf of farmers and agribusinesses that ... Inc.’s attempts to commercialize Agrisure Viptera and Agrisure Duracade, ... have not been approved for sale in China. According ... caused China to virtually ban U.S. corn imports. Because ...
(Date:11/22/2014)... SC (PRWEB) November 23, 2014 Every ... to their communities. AlignLife experience rapid growth in the ... a very unique opportunity. AlignLife of Simpsonville ... AlignLife offices for their first annual Toy Drive. These ... charity they would support with this year's toy drive. ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2
(Date:11/11/2014)... 2014  Forensicon, Inc., a Chicago ... announce the promotion of Yaniv Schiff from ... In Schiff,s new role as Director, he will lead ... forensics examiners and provide leadership within the company,s digital ... http://photos.prnewswire.com/prnh/20141110/157719 Schiff joined Forensicon in ...
(Date:11/7/2014)... BURBANK, Calif. , Nov. 7, 2014  In conjunction ... Burbank Police Departments, The Community Foundation of the ... BURBANK DNA JUSTICE PROJECT," a $250,000 initiative to ... successful initial phase. In its first six months of existence, ... desperately needed evidence support for local law enforcement. ...
(Date:11/6/2014)... cancer deaths occur because of metastasis, yet progress ... been slow. , "It,s been particularly challenging to ... Gujral, research fellow in systems biology at Harvard ... detected until after they,ve already metastasized." , Gujral ... that should help researchers better understand how metastasis ...
Breaking Biology News(10 mins):Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Migration negation 2Migration negation 3
Other Contents